7Baggers
Quarterly
Annual
    Unit: USD2029-09-30 2029-06-30 2029-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-28 2019-06-29 2019-03-30 
      
    		                       
      cash flows from operating activities:
    		                       
      net income including noncontrolling interests
    		-78,080,000 244,388,000 -92,112,000 58,057,000 59,811,000 54,771,000 35,276,000 36,347,000 43,595,000 22,780,000 23,843,000 36,142,000 26,769,000 12,027,000 14,014,000 26,905,000 46,520,000 31,125,000 14,371,000 22,304,000 61,293,000 40,145,000 13,386,000 
      adjustments to reconcile net income to net cash from operating activities
    		                       
      depreciation and amortization
    		17,518,000 31,464,000 24,531,000 32,771,000 30,154,000 28,689,000 28,359,000 29,833,000 29,578,000 30,581,000 30,509,000 37,669,000 37,232,000 34,635,000 34,673,000 32,538,000 30,952,000 32,081,000 32,409,000 33,008,000 31,027,000 31,074,000 30,591,000 
      amortization of debt issue costs
    		3,952,000 -1,488,000 4,099,000 718,000 710,000 757,000 657,000 1,070,000 657,000 653,000 649,000 644,000 643,000 865,000 665,000 596,000 391,000 196,000 173,000 171,000 173,000 385,000 244,000 
      gain on disposal of property and equipment
    		510,000 -135,000 198,000 233,000 -70,000 46,000 -3,000      60,000 30,000 267,000  21,000 61,000 -104,000     
      loss on extinguishment of debt
    		  211,018,000                     
      benefit from doubtful accounts
    		   -59,000 0   60,000 0 0 -3,000 0    -1,557,000 16,000   1,254,000 -98,000 -587,000 -279,000 
      deferred taxes
    		-3,240,000 -2,571,000 4,796,000 -709,000 -2,985,000 -2,634,000 -2,586,000 5,490,000 -4,185,000 417,000 -2,566,000 901,000 -152,000 -4,620,000 403,000 2,034,000 -1,088,000 -5,189,000 5,514,000 -18,177,000 -40,237,000 -66,410,000 1,486,000 
      foreign currency transaction gains and losses
    		6,069,000 -7,482,000 2,311,000 -1,809,000 1,249,000 520,000 -290,000 -1,529,000 2,041,000 579,000 882,000 1,809,000 712,000 175,000 2,220,000 -924,000 -754,000 -198,000 1,383,000 2,783,000 2,041,000 -970,000 618,000 
      equity in losses (earnings) of unconsolidated joint ventures
    		   52,248,000 -10,262,000 -75,000 5,840,000                 
      return on investments in unconsolidated joint ventures
    		15,863,000 -199,000 16,106,000 18,642,000 21,015,000 1,520,000 7,793,000 2,791,000 6,192,000 7,560,000 11,874,000 3,947,000 2,415,000 4,952,000 13,180,000 10,268,000 15,296,000 9,342,000 6,551,000 18,229,000 17,825,000 4,229,000 10,794,000 
      stock-based compensation
    		17,034,000 12,403,000 10,523,000 10,493,000 7,894,000 8,986,000 6,992,000 8,017,000 6,633,000 4,460,000 3,898,000 4,643,000 4,183,000 4,155,000 7,206,000 4,190,000 4,612,000 4,180,000 2,252,000 -952,000    
      contributions of treasury stock
    		7,990,000 20,352,000 15,030,000 14,100,000 14,905,000 14,732,000 14,435,000 12,679,000 15,436,000 13,490,000 13,054,000 13,593,000 14,794,000 13,365,000 13,153,000 13,321,000 12,538,000 14,597,000 14,871,000 16,865,000 12,250,000 12,279,000 12,250,000 
      changes in assets and liabilities, net of acquisitions and consolidated joint ventures:
    		                       
      accounts receivable
    		-84,563,000 78,161,000 -110,066,000 -7,217,000 58,792,000 -180,274,000 -47,482,000 -26,405,000 18,768,000 -62,991,000 -46,690,000 29,539,000 12,209,000 55,549,000 2,597,000 97,864,000 -56,869,000 42,116,000 -91,734,000 1,520,000 65,724,000 -80,315,000 -17,135,000 
      contract assets
    		55,205,000 -73,087,000 -11,715,000 516,000 -42,160,000 -29,156,000 -49,098,000 30,829,000 -44,995,000 3,346,000 -21,212,000 -11,768,000 4,902,000 40,071,000 -31,711,000 44,174,000 35,808,000 -18,393,000 -52,346,000 9,162,000 -8,319,000 -3,858,000 -46,984,000 
      prepaid expenses and other assets
    		40,428,000 14,058,000 -21,602,000 -54,945,000 429,000 -12,951,000 -27,948,000 -10,177,000 12,293,000 -8,017,000 4,496,000 798,000 -8,443,000 -5,767,000 -5,386,000         
      accounts payable
    		-5,797,000 30,777,000 31,685,000 -23,797,000 13,251,000 27,034,000 8,009,000 201,000 7,161,000 31,263,000 -39,342,000 7,575,000 -4,969,000 -27,714,000 -6,658,000 9,568,000 -1,846,000 -26,016,000 19,788,000 -10,177,000 -2,429,000 23,665,000 -28,182,000 
      accrued expenses and other current liabilities
    		119,974,000 -16,729,000 -77,591,000 70,177,000 59,927,000 44,234,000 -10,898,000 -16,341,000 27,534,000 -3,180,000 -4,134,000 11,719,000 11,139,000 -28,613,000 -68,928,000 -45,496,000 70,884,000 2,353,000 -24,336,000 38,180,000 22,423,000 41,786,000 -24,023,000 
      contract liabilities
    		-14,129,000 31,562,000 -17,090,000 22,936,000 -15,019,000 60,409,000 16,113,000 14,641,000 13,305,000 12,415,000 945,000 -14,113,000 -10,337,000 10,129,000 -16,086,000 -11,580,000 -7,047,000 -22,463,000 11,416,000 -557,000 9,239,000 -3,420,000 14,884,000 
      income taxes
    		-54,740,000 56,908,000 -51,080,000 -14,509,000 7,086,000 3,901,000 6,408,000 -4,809,000 -1,947,000 -1,599,000 4,706,000 3,376,000 1,904,000 -3,670,000 1,268,000 3,681,000 -10,809,000 10,260,000 -6,212,000 -2,402,000 4,204,000 -3,578,000 -3,645,000 
      other long-term liabilities
    		-22,882,000 4,801,000 -4,521,000 12,287,000 -1,147,000 2,376,000 -567,000 12,474,000 -9,843,000 4,963,000 -986,000 -26,261,000 -6,248,000 8,287,000 -19,312,000 -12,962,000 13,074,000 14,451,000 -43,099,000 15,910,000 -6,959,000 32,362,000 -12,265,000 
      net cash from operating activities
    		248,826,000 211,434,000 -63,420,000 190,133,000 203,580,000 22,976,000 -8,990,000 89,158,000 123,032,000 51,050,000 -25,714,000 89,860,000 77,251,000 104,428,000 -65,965,000 175,722,000 144,883,000 87,539,000 -118,983,000 89,612,000 179,123,000 11,613,000 -60,108,000 
      cash flows from investing activities:
    		                       
      capital expenditures
    		-7,537,000 -13,473,000 -9,436,000 -9,519,000 -12,921,000 -9,810,000 -8,146,000 -10,809,000 -6,196,000 -9,115,000 -4,473,000 -8,302,000 -3,632,000 -4,722,000 -4,449,000 -4,858,000 -6,240,000 -10,301,000 -12,637,000 -23,567,000 -18,077,000 -14,912,000 -11,041,000 
      free cash flows
    		241,289,000 197,961,000 -72,856,000 180,614,000 190,659,000 13,166,000 -17,136,000 78,349,000 116,836,000 41,935,000 -30,187,000 81,558,000 73,619,000 99,706,000 -70,414,000 170,864,000 138,643,000 77,238,000 -131,620,000 66,045,000 161,046,000 -3,299,000 -71,149,000 
      proceeds from sale of property and equipment
    		93,000 33,000 2,000 272,000 209,000 46,000 19,000 198,000 322,000 139,000 112,000 280,000 665,000 220,000 164,000 493,000 110,000 458,000 485,000 965,000 951,000 1,738,000 135,000 
      payments for acquisitions, net of cash acquired
    		-81,017,000   -6,440,000 -173,224,000   -195,000 0   -584,000 -197,928,000 -808,000 1,064,000     864,000 -208,208,000 0 -287,482,000 
      investments in unconsolidated joint ventures
    		-79,950,000 580,000 -36,076,000 -37,984,000 -57,091,000 -11,491,000 -13,016,000 -3,985,000 -2,409,000 -1,515,000 -9,713,000 -2,357,000 -9,729,000 -4,133,000 -22,240,000 -3,069,000 -4,125,000 -3,794,000 -50,000 -13,133,000 -6,397,000 -144,000 -4,905,000 
      return of investments in unconsolidated joint ventures
    		-11,895,000   4,946,000 0   0   644,000 43,000 2,000 611,000 116,000 36,000 0   5,778,000 2,229,000 2,169,000 2,234,000 
      proceeds from sales of investments in unconsolidated joint ventures
    		   0 0 0 381,000     477,000 0 35,000 14,300,000         
      net cash from investing activities
    		-180,306,000 -118,798,000 -45,510,000 -48,725,000 -243,027,000 -63,456,000 -20,762,000 -14,791,000 1,160,000 -390,407,000 -13,430,000 -10,443,000 -210,622,000 -8,797,000 -11,045,000 -310,292,000 -10,255,000 -13,620,000 -12,202,000 -29,093,000 -229,502,000 -11,149,000 -301,059,000 
      cash flows from financing activities:
    		                       
      proceeds from borrowings under credit agreement
    		-90,500,000 90,500,000 153,200,000    5,700,000  333,800,000              290,000,000 
      repayments of borrowings under credit agreement
    		90,500,000 -90,500,000 -153,200,000    -5,700,000  -432,600,000              -60,000,000 
      convertible debt repurchase loss
    		                       
      equity in losses of unconsolidated joint ventures
    		 -731,000 2,060,000                     
      cash flows from operating activities
    		                       
      changes in assets and liabilities, net of acquisitions and newly consolidated joint ventures
    		                       
      cash flows from investing activities
    		                       
      cash flows from financing activities
    		                       
      proceeds from delayed draw term loan
    		                       
      repayment of private placement debt
    		                       
      payments for acquired warrants
    		       0 0               
      proceeds from issuance of convertible notes due 2029
    		                       
      repurchases of convertible notes due 2025
    		                       
      payments for debt issuance costs
    		                       
      contributions by noncontrolling interests
    		   1,330,000 1,337,000 0 200,000 1,967,000 5,472,000 1,601,000 1,226,000 66,000 816,000 865,000 7,000 1,724,000 268,000 2,000 221,000 1,094,000    
      distributions to noncontrolling interests
    		   -340,000 -9,669,000 -1,849,000 -638,000 -9,838,000 -3,946,000 -2,035,000 -8,309,000 -686,000 -15,410,000 -12,847,000 -8,989,000 -1,347,000 -2,864,000 -1,245,000 -360,000 -6,907,000    
      repurchases of common stock
    		   -3,000,000 0 -2,000,000 -6,000,000 -2,500,000 -3,952,000 -10,000,000 -5,548,000 -13,000,000            
      taxes paid on vested stock
    		   -360,000 -103,000 -774,000 -6,064,000 -907,000 -172,000 -192,000 -5,771,000 0 0 0 -2,242,000 0 0 0 -1,149,000     
      capped call transactions
    		                       
      bond hedge termination
    		                       
      redemption of warrants
    		                       
      proceeds from issuance of common stock
    		   3,119,000 0   2,653,000 0   2,782,000 0   2,702,000 0       
      net cash from financing activities
    		   -74,251,000 66,565,000 -1,683,000 -12,502,000 40,183,000 -102,268,000 180,855,000 -18,402,000 -10,838,000 -73,406,000 -11,035,000 -11,224,000 3,136,000 345,937,000 -64,559,000 63,712,000 -11,266,000 -14,191,000 80,870,000 210,623,000 
      effect of exchange rate changes
    		   380,000 -301,000 313,000 154,000 450,000 -1,257,000 -1,388,000 425,000 -1,399,000 -1,108,000 581,000 430,000 892,000 572,000 538,000 -1,179,000 -341,000 -351,000 -420,000 -182,000 
      net increase in cash, cash equivalents and restricted cash
    		                       
      cash, cash equivalents and restricted cash
    		                       
      beginning of year
    		   0 0 0 262,539,000 0 0 0 343,883,000 0 0 0 487,215,000 0 0 0 195,374,000 0 0 0 281,195,000 
      end of year
    		                       
      cash paid during the year for
    		                       
      interest
    		                       
      proceeds from borrowings
    		   109,400,000 324,100,000             49,100,000 131,500,000 67,200,000 180,000,000   
      repayments of borrowings
    		   -184,400,000 -249,100,000             -114,100,000 -66,500,000 -67,200,000 -180,000,000   
      payments for debt costs and credit agreement
    		       8,000    0 -111,000       0 0 0 -286,000 
      changes in assets and liabilities, net of acquisitions and newly consolidated joint ventures:
    		                       
      cash, cash equivalents and restricted cash:
    		                       
      end of period
    		    26,817,000 -41,850,000 220,439,000  20,667,000 -159,890,000 286,762,000  -207,885,000 85,177,000 399,411,000  481,137,000 9,898,000 126,722,000  -64,921,000 80,914,000 130,469,000 
      amortization of convertible notes discount
    		               2,554,000        
      (gain) loss on disposal of property and equipment
    		       97,000 -165,000 -57,000 -39,000           3,000 -27,000 
      equity in earnings of unconsolidated joint ventures
    		       -6,110,000 974,000 -5,613,000 -5,598,000 -10,334,000 -9,570,000 -9,428,000 -7,530,000 -3,435,000 -16,741,000 -3,769,000 -6,114,000 -12,416,000 -7,274,000 -11,634,000 -10,397,000 
      proceeds from issuance of convertible notes
    		               0        
      payments for purchase of bond hedges
    		               0        
      proceeds from issuance of warrants
    		               0        
      transaction costs paid in connection with convertible notes issuance
    		               57,000        
      loss on disposal of property and equipment
    		                   -3,000    
      dividend paid
    		                   0 0   
      amortization of deferred gain
    		                       
      gain associated with claim on long-term contract
    		                       
      billings in excess of costs
    		                       
      benefit from contract losses
    		                       
      purchase of treasury stock
    		                 807,000 -813,000 -5,453,000 0 -6,000 -813,000 
      prepaid expenses and current assets
    		                8,648,000 2,767,000 -3,766,000 -25,090,000 7,947,000 -3,543,000 -1,424,000 
      net increase in cash, cash equivalents, and restricted cash
    		                      -150,726,000 
      balance at june 30, 2020
    		                       
      comprehensive income
    		                       
      net income
    		                       
      foreign currency translation gain
    		                       
      pension adjustments
    		                       
      contributions
    		                       
      distributions
    		                  -164,000     
      issuance of equity securities, net of retirements
    		                       
      equity component value of convertible note issuance
    		                       
      purchase of convertible note hedge
    		                       
      sale of common stock warrants
    		                       
      balance at september 30, 2020
    		                       
      balance at june 30, 2019
    		                0       
      ipo proceeds
    		                   0 -452,000   
      esop shares at redemption value
    		                -1,282,164,000       
      balance at september 30, 2019
    		                       
      balance at march 31, 2020
    		                       
      balance at march 31, 2019
    		                 0 1,875,332,000     
      conversion of s-corp to c-corp
    		                       
      balance at december 31, 2019
    		                       
      adoption of asu 2016-13
    		                       
      balance at december 31, 2018
    		                  1,876,309,000     
      asc 842 transition adjustment
    		                       
      deferred payments for acquisitions
    		                       
      contributions by (distributions to) noncontrolling interests
    		                     5,638,000 -18,278,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.